Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial
Hee Jin Cho(Kyungpook National University), Hyo Song Kim(Yonsei University)
Cited by 29
Related Papers
Spatiotemporal Evolution of the Primary Glioblastoma Genome
|Cancer Cell|2015|320
Development and validation of a prognostic and predictive 32-gene signature for gastric cancer
|Nature Communications|2022|114
Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma
|Oncotarget|2014|34